Key Takeaways

EMD Serono’s GONAL-F fertility drug will be offered at a lower price through the new TrumpRx website

The administration also introduced new guidance for employers to provide their own fertility coverage

Experts say lowering prices will help many families

MONDAY, Oct. 20, 2025 (HealthDay News) — The Trump administration announced that Boston-based drugmaker EMD Serono will lower the price of one of its leading fertility drugs as part of push to make in vitro fertilization (IVF) more affordable.

The company’s drug GONAL-F , which helps stimulate ovulation, will soon be available at a discount through TrumpRx, a federal website expected to launch in 2026.

The site will allow patients to purchase prescription drugs directly from manufacturers, officials said.

“We want

See Full Page